Literature DB >> 2179037

Differential expression of transferrin receptor in duodenal mucosa in iron overload. Evidence for a site-specific defect in genetic hemochromatosis.

M Lombard1, A B Bomford, R J Polson, A J Bellingham, R Williams.   

Abstract

In genetic hemochromatosis, metabolic studies have demonstrated inappropriately increased iron absorption by cells of the duodenal mucosa. It is not clear whether this reflects an intrinsic abnormality of iron homeostasis at this site or is a consequence of a more generalized defect in cellular iron metabolism particularly involving the liver. We have previously used the expression of iron-related proteins as markers of iron homeostasis and have demonstrated normal regulation of the transferrin receptor and ferritin in the liver in this condition. In the present study we used immunohistochemical techniques to study transferrin-receptor expression in the gastrointestinal epithelium in normal subjects and patients with iron overload. In untreated genetic hemochromatosis and normal subjects, villus epithelial cells expressed receptor in the basolateral, subnuclear region. In contrast, in patients with secondary iron overload, receptor staining was absent in villus epithelial cells. The cells in the duodenal crypts showed intense staining for the transferrin receptor in all subjects investigated, a finding consistent with the known behavior of this receptor in proliferating cells. Given that body iron stores in both types of iron overload were comparable, these findings indicating a failure of down-regulation of the villus enterocyte transferrin receptor in genetic hemochromatosis may reflect the presence of a regulatory defect associated with the inability to control iron absorption in this condition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179037     DOI: 10.1016/0016-5085(90)90022-s

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

Review 1.  Hereditary (primary) haemochromatosis.

Authors:  N D Finlayson
Journal:  BMJ       Date:  1990 Aug 18-25

Review 2.  Genetic haemochromatosis.

Authors:  A B Bomford; I W Dymock; E B Hamilton
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Regulation of intestinal non-haem iron absorption.

Authors:  M Lombard; E Chua; P O'Toole
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

4.  Site of principal metabolic defect in idiopathic haemochromatosis: insights from transplantation of an affected organ.

Authors:  P L Dabkowski; P W Angus; R A Smallwood; J Ireton; R M Jones
Journal:  BMJ       Date:  1993-06-26

Review 5.  The role of iron and iron binding proteins in lymphocyte physiology and pathology.

Authors:  J D Kemp
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

6.  Exclusion of ferritins and iron-responsive element (IRE)-binding proteins as candidates for the hemochromatosis gene.

Authors:  H Zheng; D Bhavsar; A Volz; A Ziegler; J Drysdale
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

7.  A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis.

Authors:  K B Raja; D Pountney; A Bomford; R Przemioslo; D Sherman; R J Simpson; R Williams; T J Peters
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

8.  Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1.

Authors:  R E Fleming; M C Migas; X Zhou; J Jiang; R S Britton; E M Brunt; S Tomatsu; A Waheed; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.

Authors:  T Kelleher; E Ryan; S Barrett; M Sweeney; V Byrnes; C O'Keane; J Crowe
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

10.  Transplantation of a donor liver with haemochromatosis: evidence against an inherited intrahepatic defect.

Authors:  P C Adams; C N Ghent; D R Grant; J V Frei; W J Wall
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.